Correlation Between AstraZeneca PLC and Investor
Can any of the company-specific risk be diversified away by investing in both AstraZeneca PLC and Investor at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AstraZeneca PLC and Investor into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AstraZeneca PLC and Investor AB ser, you can compare the effects of market volatilities on AstraZeneca PLC and Investor and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AstraZeneca PLC with a short position of Investor. Check out your portfolio center. Please also check ongoing floating volatility patterns of AstraZeneca PLC and Investor.
Diversification Opportunities for AstraZeneca PLC and Investor
0.28 | Correlation Coefficient |
Modest diversification
The 3 months correlation between AstraZeneca and Investor is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding AstraZeneca PLC and Investor AB ser in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Investor AB ser and AstraZeneca PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AstraZeneca PLC are associated (or correlated) with Investor. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Investor AB ser has no effect on the direction of AstraZeneca PLC i.e., AstraZeneca PLC and Investor go up and down completely randomly.
Pair Corralation between AstraZeneca PLC and Investor
Assuming the 90 days trading horizon AstraZeneca PLC is expected to under-perform the Investor. In addition to that, AstraZeneca PLC is 1.81 times more volatile than Investor AB ser. It trades about -0.18 of its total potential returns per unit of risk. Investor AB ser is currently generating about -0.04 per unit of volatility. If you would invest 30,430 in Investor AB ser on September 2, 2024 and sell it today you would lose (700.00) from holding Investor AB ser or give up 2.3% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
AstraZeneca PLC vs. Investor AB ser
Performance |
Timeline |
AstraZeneca PLC |
Investor AB ser |
AstraZeneca PLC and Investor Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with AstraZeneca PLC and Investor
The main advantage of trading using opposite AstraZeneca PLC and Investor positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AstraZeneca PLC position performs unexpectedly, Investor can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Investor will offset losses from the drop in Investor's long position.AstraZeneca PLC vs. BioInvent International AB | AstraZeneca PLC vs. Hansa Biopharma AB | AstraZeneca PLC vs. ExpreS2ion Biotech Holding | AstraZeneca PLC vs. Saniona AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |